Evolving Treatment Paradigms for Metastatic Liver Cancer

EP. 1: NASH and Cirrhosis in HCC

February 28th 2020

EP. 2: Cirrhosis Prognosis: The Child-Pugh Score

February 28th 2020

EP. 3: Diagnosing Patients With HCC

February 28th 2020

EP. 4: Metastatic HCC: Locoregional to Systemic Therapy

February 28th 2020

EP. 5: IMbrave150 Phase III Trial for MHCC

February 28th 2020

EP. 6: IMBrave150 Regimen: Managing Varices

February 28th 2020

EP. 7: Novel Combinations for Treating mHCC

February 28th 2020

EP. 8: MHCC Combination Therapies: Selection and Differentiation

February 28th 2020

EP. 9: COSMIC-312 Trial Overview

February 28th 2020

EP. 10: I/O Therapy Approach After First-Line Treatment

February 28th 2020

EP. 11: Relapsed/Refractory HCC: Third-Line Approach

February 28th 2020

EP. 12: Treatment Approach After IMpower150 Regimen

February 28th 2020

EP. 13: Therapy Options for Hepatitis B/C-Related HCC

February 28th 2020

EP. 14: Etiologic Reponses to Treating Hepatitis B/C-Related HCC

February 28th 2020

EP. 15: The Future of HCC Management

February 28th 2020